Serratus Posterior Superior Interfascial Plane Block for Breast Surgery
Breast Diseases
About this trial
This is an interventional treatment trial for Breast Diseases focused on measuring Mastectomy and axillary dissection surgery, Postoperative pain management, Serratus Posterior Superior Interfascial Plane Block
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists (ASA) classification I-II Scheduled for mastectomy and axillary dissection surgery under general anesthesia Exclusion Criteria: receiving anticoagulant treatment, known study drugs allergy, opioid addiction infection of the skin at the site of the block, pregnancy or lactation,
Sites / Locations
- Istanbul Medipol University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Other
Group S = SPSIPB group
Group C = Control group
A high-frequency linear US probe (11-12 MHz, Vivid Q) will be covered with a sterile sheath, and an 80 mm block needle (Braun 360°) will be used. The procedure will be performed with the patient in the lateral decubitus position. After the scapula is shifted slightly laterally, the US probe is placed sagittal at the upper corner of the spina scapula, and the serratus posterior superior muscle is visualized with the third rib. The in-plane technique will be used. The block needle will be advanced in the craniocaudal direction to enter between the serratus posterior superior and the third rib. The block location will be confirmed by injecting 5 ml of saline between the rib and the muscle. After the block location is confirmed, 30 ml of 0.25% concentration bupivacaine will be used.
The wound infiltration with 30 ml of 0.25% concentration of bupivacaine will be performed by the surgical team.